Bausch Health Cos Shares Outstanding 2010-2023 | BHC
Bausch Health Cos shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Bausch Health Cos Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
365 |
| 2022 |
362 |
| 2021 |
359 |
| 2020 |
355 |
| 2019 |
352 |
| 2018 |
351 |
| 2017 |
352 |
| 2016 |
347 |
| 2015 |
343 |
| 2014 |
342 |
| 2013 |
321 |
| 2012 |
305 |
| 2011 |
326 |
| 2010 |
196 |
| 2009 |
159 |
Bausch Health Cos Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-12-31 |
365 |
| 2023-09-30 |
365 |
| 2023-06-30 |
367 |
| 2023-03-31 |
363 |
| 2022-12-31 |
362 |
| 2022-09-30 |
363 |
| 2022-06-30 |
362 |
| 2022-03-31 |
361 |
| 2021-12-31 |
359 |
| 2021-09-30 |
364 |
| 2021-06-30 |
359 |
| 2021-03-31 |
357 |
| 2020-12-31 |
355 |
| 2020-09-30 |
358 |
| 2020-06-30 |
355 |
| 2020-03-31 |
353 |
| 2019-12-31 |
352 |
| 2019-09-30 |
352 |
| 2019-06-30 |
352 |
| 2019-03-31 |
351 |
| 2018-12-31 |
351 |
| 2018-09-30 |
352 |
| 2018-06-30 |
351 |
| 2018-03-31 |
351 |
| 2017-12-31 |
352 |
| 2017-09-30 |
352 |
| 2017-06-30 |
350 |
| 2017-03-31 |
350 |
| 2016-12-31 |
347 |
| 2016-09-30 |
350 |
| 2016-06-30 |
345 |
| 2016-03-31 |
345 |
| 2015-12-31 |
343 |
| 2015-09-30 |
351 |
| 2015-06-30 |
344 |
| 2015-03-31 |
343 |
| 2014-12-31 |
342 |
| 2014-09-30 |
341 |
| 2014-06-30 |
341 |
| 2014-03-31 |
335 |
| 2013-12-31 |
321 |
| 2013-09-30 |
334 |
| 2013-06-30 |
314 |
| 2013-03-31 |
306 |
| 2012-12-31 |
305 |
| 2012-09-30 |
312 |
| 2012-06-30 |
305 |
| 2012-03-31 |
308 |
| 2011-12-31 |
326 |
| 2011-09-30 |
323 |
| 2011-06-30 |
331 |
| 2011-03-31 |
333 |
| 2010-12-31 |
196 |
| 2010-09-30 |
163 |
| 2010-06-30 |
161 |
| 2010-03-31 |
158 |
| 2009-12-31 |
159 |
| 2009-09-30 |
159 |
| 2009-06-30 |
158 |
| 2009-03-31 |
158 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.164B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
